SKVY yields 2000000.00% · JNJ yields 2.13%● Live data
📍 SKVY pulled ahead of the other in Year 1
Combined, SKVY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKVY + JNJ for your $10,000?
Sentry Technology Corp. designs, manufactures, markets, and services closed circuit television (CCTV), library patron self service, and radio frequency identification (RFID) solutions, as well as EAS security systems. It offers SentryVision SmartTrack, a traveling video system that transmit images from a PTZ camera mounted on a carriage that travels along a rail mounted to the ceiling of any facility; VideoRailway, a traveling camera technology; security and information services through inventory management, self-service, and book detection systems to school, public, and academic libraries; and OperationalVideo, a browser based video application to assist retailers with real time management of security, merchandising audits, and employee procedure compliance. The company also offers EAS security systems, including electromagnetic and RF systems for reducing theft in bookstores; and designs, installs, and maintains CCTV systems for retailers, transportation and distribution, and commercial and industrial companies. It serves retailers, transportation and distribution hubs, couriers and public transportation facilities, libraries, and data centers through dealers in North America, Europe, Latin America, the Middle East, Asia, and Africa. The company was founded in 1996 and is based in Ronkonkoma, New York.
Full SKVY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.